Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
Calkins H, Willems S, Gerstenfeld EP, Verma A, Schilling R, Hohnloser SH, Okumura K, Serota H, Nordaby M, Guiver K, Biss B, Brouwer MA, Grimaldi M; RE-CIRCUIT Investigators. Calkins H, et al. N Engl J Med. 2017 Apr 27;376(17):1627-1636. doi: 10.1056/NEJMoa1701005. Epub 2017 Mar 19. N Engl J Med. 2017. PMID: 28317415 Free article. Clinical Trial.
Hydroxychloroquine-induced cardiomyopathy: a case report.
Muthukrishnan P, Roukoz H, Grafton G, Jessurun J, Colvin-Adams M. Muthukrishnan P, et al. Among authors: roukoz h. Circ Heart Fail. 2011 Mar;4(2):e7-8. doi: 10.1161/CIRCHEARTFAILURE.110.959916. Circ Heart Fail. 2011. PMID: 21406675 No abstract available.
Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies.
Garcia S, Sandoval Y, Roukoz H, Adabag S, Canoniero M, Yannopoulos D, Brilakis ES. Garcia S, et al. Among authors: roukoz h. J Am Coll Cardiol. 2013 Oct 15;62(16):1421-31. doi: 10.1016/j.jacc.2013.05.033. Epub 2013 Jun 7. J Am Coll Cardiol. 2013. PMID: 23747787 Free article.
Usefulness of Atrial Fibrillation as a Marker for Adverse Cardiovascular Outcomes in Both Primary and Secondary Prevention in Patients With Implantable Cardioverter-Defibrillators.
Chang IC, Agamawi YM, Austin E, Adkisson WO, Roukoz H, von Wald LN, Sakaguchi S, Benditt DG, Chen LY. Chang IC, et al. Among authors: roukoz h. Am J Cardiol. 2016 Nov 15;118(10):1497-1502. doi: 10.1016/j.amjcard.2016.08.016. Epub 2016 Aug 23. Am J Cardiol. 2016. PMID: 27649879
66 results